HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanistic rationale for factor XIII cotreatment in haemophilia.

AuthorsJoan D Beckman, Alisa S Wolberg
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 25 Issue 6 Pg. e377-e378 (Nov 2019) ISSN: 1365-2516 [Electronic] England
PMID31577382 (Publication Type: Letter)
Chemical References
  • Hemostatics
  • Factor XIII
Topics
  • Factor XIII (therapeutic use)
  • Hemophilia A (blood, complications, therapy)
  • Hemorrhage (blood, complications, therapy)
  • Hemostatics (therapeutic use)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: